NASDAQ
QTNT

Quotient Ltd

Healthcare Equipment & Supplies
Healthcare

Prices are adjusted according to historical splits.

Quotient Ltd Stock Price

Vitals

Today's Low:
$0.04
Today's High:
$0.06
Open Price:
$0.04
52W Low:
$0.032
52W High:
$9.72
Prev. Close:
$0.0496
Volume:
20686

Company Statistics

Market Cap.:
$1.34 million
Book Value:
-53.617
Revenue TTM:
$37.63 million
Operating Margin TTM:
-323.27%
Gross Profit TTM:
$14.95 million
Profit Margin:
0%
Return on Assets TTM:
-40.28%
Return on Equity TTM:
-737.71%

Company Profile

Quotient Ltd had its IPO on 2014-04-25 under the ticker symbol QTNT.

The company operates in the Healthcare sector and Healthcare Equipment & Supplies industry. Quotient Ltd has a staff strength of 450 employees.

Stock update

Shares of Quotient Ltd opened at $0.04 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.04 - $0.06, and closed at $0.04.

This is a -19.35% slip from the previous day's closing price.

A total volume of 20,686 shares were traded at the close of the day’s session.

In the last one week, shares of Quotient Ltd have slipped by -21.57%.

Quotient Ltd's Key Ratios

Quotient Ltd has a market cap of $1.34 million, indicating a price to book ratio of 54.8734 and a price to sales ratio of 0.031.

In the last 12-months Quotient Ltd’s revenue was $37.63 million with a gross profit of $14.95 million and an EBITDA of $-115160000. The EBITDA ratio measures Quotient Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Quotient Ltd’s operating margin was -323.27% while its return on assets stood at -40.28% with a return of equity of -737.71%.

In Q4, Quotient Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 6.5%.

Quotient Ltd’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-1.34 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Quotient Ltd’s profitability.

Quotient Ltd stock is trading at a EV to sales ratio of 5.9964 and a EV to EBITDA ratio of -2.179. Its price to sales ratio in the trailing 12-months stood at 0.031.

Quotient Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$119.33 million
Total Liabilities
$29.63 million
Operating Cash Flow
$0
Capital Expenditure
$566000
Dividend Payout Ratio
0%

Quotient Ltd ended 2024 with $119.33 million in total assets and $0 in total liabilities. Its intangible assets were valued at $119.33 million while shareholder equity stood at $-208885000.00.

Quotient Ltd ended 2024 with $0 in deferred long-term liabilities, $29.63 million in other current liabilities, 558639000.00 in common stock, $-823160000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $11.93 million and cash and short-term investments were $11.93 million. The company’s total short-term debt was $4,387,000 while long-term debt stood at $240.29 million.

Quotient Ltd’s total current assets stands at $40.50 million while long-term investments were $15.58 million and short-term investments were $0.00. Its net receivables were $6.65 million compared to accounts payable of $2.81 million and inventory worth $14.33 million.

In 2024, Quotient Ltd's operating cash flow was $0 while its capital expenditure stood at $566000.

Comparatively, Quotient Ltd paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.04
52-Week High
$9.72
52-Week Low
$0.032
Analyst Target Price
$60

Quotient Ltd stock is currently trading at $0.04 per share. It touched a 52-week high of $9.72 and a 52-week low of $9.72. Analysts tracking the stock have a 12-month average target price of $60.

Its 50-day moving average was $0.13 and 200-day moving average was $5.79 The short ratio stood at 0.23 indicating a short percent outstanding of 0%.

Around 211.5% of the company’s stock are held by insiders while 4575.2% are held by institutions.

Frequently Asked Questions About Quotient Ltd

The stock symbol (also called stock or share ticker) of Quotient Ltd is QTNT

The IPO of Quotient Ltd took place on 2014-04-25

Similar Industry Stocks (Healthcare Equipment & Supplies)

Last Price
Chg
Chg%
$46.5
-0.61
-1.29%
$164.7
-15.45
-8.58%
$627.65
-1.05
-0.17%
$1.12
0.03
+2.75%
$5052.45
-197.15
-3.76%
$131.15
-7.25
-5.24%
$36.61
-2.59
-6.61%
$0.16
0.01
+3.99%
$1.3
-0.03
-2.26%
$59.4
0.35
+0.59%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.

Address

Business Park Terre Bonne, Eysins, Switzerland, 1262